多家厂商称介入手术机器人已能实现精准执行，临床医生怎么看？

Core Insights - The key to charging for surgical robots lies in their ability to genuinely advance medical technology and meet core surgical needs, with room for improvement still evident [1][4] - The National Healthcare Security Administration (NHSA) has issued guidelines that standardize pricing for robotic surgeries and remote surgical assistance, categorizing them into three pricing tiers based on the robot's level of involvement [2][6] Group 1: Pricing Guidelines and Robot Capabilities - The NHSA's guidelines introduce a tiered pricing model for surgical robots based on their participation level, with higher fees for robots that provide more comprehensive and precise assistance [2][6] - Surgical robots are now capable of assisting in all critical steps of surgery, including precise execution of organ removal and reconstruction, enhancing flexibility and accuracy compared to traditional methods [2][3] Group 2: Industry Developments and Innovations - Companies like Weimai Medical and Aibo Hechuang have developed surgical robots that meet the NHSA's pricing standards, focusing on functionalities such as remote operation and precise execution [3][4] - The next generation of surgical robots is being developed with a focus on higher intelligence, enhanced feedback technology, and integration of multimodal imaging to improve surgical planning and execution [6][7] Group 3: Clinical Perspectives and Future Outlook - Clinical experts express caution regarding the current capabilities of surgical robots, noting that while they can perform precise tasks, they still rely heavily on the expertise of surgeons for complex cases [4][5] - The implementation of standardized pricing is expected to accelerate the commercialization of surgical robots, addressing previous uncertainties about who would bear the costs [6][7]